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Background: Inherited genetic defects play an important role in congenital hearing loss, contributing to about
60% of deafness occurring in infants. Hereditary nonsyndromic hearing loss is highly heterogeneous, and most
patients with a presumed genetic etiology lack a specific molecular diagnosis.
Methods: By whole exome sequencing, we identified responsible gene of family 4794 with autosomal recessively
nonsyndromic hearing loss (ARNSHL). We also used DNA from 56 Chinese familial patients with ARNSHL (autosomal
recessive nonsyndromic hearing loss) and 108 ethnicity-matched negative samples to perform extended variants
analysis.
Results: We identified MYO15A c.IVS25 + 3G > A and c.8375 T > C (p.V2792A) as the disease-causing mutations. Both
mutations co-segregated with hearing loss in family 4794, but were absent in the 56 index patients and 108
ethnicity-matched controls.
Conclusions: Our results demonstrated that the hearing loss of family 4794 was caused by novel compound
heterozygous mutations in MYO15A.
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Hearing loss is a common sensory defect that can sig-
nificantly impact quality of life. The majority of con-
genital cases are attributable to genetic factors [1].
Nonsyndromic hereditary forms, in which the hearing
loss is the only clinical sign, are genetically heterogeneous.
Autosomal recessive nonsyndromic hearing loss (ARNSHL)
is the most common type and accounts for ~80% of cases
of inherited hearing loss. To date, 61 genes and more
than 100 genetic loci have been implicated in ARNSHL
(see URL1). For many decades, linkage analysis has been
the most powerful and widely used strategy to identify the
gene defects responsible for inherited disorders. However,* Correspondence: daipu301@vip.sina.com
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reproduction in any medium, provided the orthis approach is time consuming and requires the availability
of cohorts of homogeneous and informative, possibly large
families. As the molecular basis of deafness in most of the
Chinese pedigrees is unsolved, we predict that many new
deafness genes and mutations remain to be identified.
Whole-exome sequencing (WES) has become a highly
efficient strategy for identifying novel causative genes and
mutations involved in heritable disease [2]. Both simple
nonsyndromic and complex syndromic forms of hearing
loss can be resolved efficiently using WES, especially in
small families with distinct and interesting phenotypes that
were once too small to map [3]. To date, nine syndromic
or nonsyndromic deafness genes have been identified using
targeted genomic enrichment and next-generation se-
quencing: TPRN, GPSM2, CEACAM16, SMPX, HSD17B4,
HARS2, MASP1, DNMT1, and TSPEAR [4-12]. As WES
typically identifies many thousands of exomic variants, a
selection strategy is important to facilitate the identifica-
tion of the mutation that causes the disease [13,14]. With. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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from one family may be powerful for quickly identifying
new susceptibility genes or mutations.
MYO15A has 66 exons and its coding protein, myosin
XVa, is composed of 3,530 amino acids, and is critical
for the formation of stereocilia in hair cells of the coch-
lea. In the organ of Corti, myosin XVa is localized exclu-
sively at the tips of stereocilia and is a motor protein
that uses energy from ATP hydrolysis to move along
actin filaments [15]. The tip of a stereocilium is the
site of stereocilia growth and one of the proposed sites
of mechano-electrical transduction [15]. Myosin XVa-
deficient mice were reported to lack any links between
stereocilia, suggesting a complete disruption of the
mechanotransduction machinery [16]. Therefore, it was
assumed that myosin XVa is required for proper forma-
tion and function of the mechanotransduction appar-
atus. Mutations in this gene cause DFNB3 hearing loss
in individuals from different populations worldwide [17].
Here, we report a family with two siblings affected by
severe-to-profound sensorineural hearing loss. Muta-
tions in GJB2 and SLC26A4 were previously excluded.
As the family is small and non-consanguineous, neither
linkage analysis nor homozygosity mapping would have
been informative for identifying the causative gene.
Therefore, we used WES to identify the gene responsible
for deafness in this family. WES was carried out in four
members of family 4794 (two affected siblings and their
parents), followed by validation. The results identified
two novel compound heterozygous disease-segregating
mutations, c.IVS25 + 3G >A and c.8375 T >C (p.V2792A),
in the MYO15A gene. To exclude the possibility that these
mutations were polymorphisms, DNA samples of 56
affected and 108 unaffected individuals were also analyzed.
This is the first study to identify MYO15A mutations as the
ARNSHL-associated gene in the Chinese deaf population.
Methods and materials
Clinical data
Family 4794 is a two-generation Chinese family with auto-
somal recessive prelingual non-syndromic sensorineural
hearing loss. To screen for candidate mutations, we used
108 ethnicity-matched controls and 56 affected DNA
samples from the Department of Otolaryngology, Head and
Neck Surgery, Chinese PLA General Hospital. The 56 index
patients were from families presenting with ARNSHL and
in whom mutations of GJB2 and SLC26A4 had been previ-
ously excluded. Fully informed written consent was ob-
tained from each subject. The study was approved by the
Chinese PLA General Hospital Research Ethics Commit-
tee. Medical histories of the members of family 4794 were
obtained using a questionnaire regarding the following as-
pects of the condition Otoscopy, physical examination,
and pure tone audiometric examination (at frequenciesfrom 250 to 8000 Hz) were performed to identify the
phenotype. Immittance testing was applied to evaluate
middle-ear pressure, ear canal volumes, and tympanic
membrane mobility. Physical examination of all members
revealed no signs of systemic illness or dysmorphic features.
Computed tomography (CT) scan of the temporal bone
was performed. The diagnosis of profound sensorineural
hearing impairment was made according to the ICD-10
criteria based on audiometric examination. Tandem gait
and Romberg tests were performed to evaluate balance.
Preparation of DNA
All genomic DNA was extracted from peripheral blood
using a blood DNA extraction kit according to the protocol
provided by the manufacturer (TianGen, Beijing, China).
Whole-exome capture and sequencing
Whole-exome capture and sequencing have been described
in detail previously [18]. In brief, genomic DNA was
captured using the NimblegenSeqCap EZ Library (64 Mb
for I1, I2, II:1, II:2). DNA was sheared, ligated to adaptors,
extracted, amplified by ligation-mediated PCR (LM-PCR),
and then hybridized to the Nimblegen SeqCap EZ Library
for enrichment. The each captured library was loaded onto
the Illumina Hiseq2000 platform. Raw image files were
processed by Illumina base calling software 1.7.
Read mapping, variant detection, filtering, and annota-
tion have been described in detail previously [18]. Under
the assumption of an autosomal-recessive pattern of in-
heritance, only variants that were homozygous or com-
pound heterozygous in the two affected siblings and
heterozygous in their parents were selected as candidates.
Mutation validation
After filtering against multiple databases, Sanger sequen-
cing was used to determine if any of the potential novel
mutations in known causative genes of ARNSHL co-
segregated with the disease phenotype in this family.
Direct polymerase chain reaction (PCR) products were
sequenced using Bigdye terminator v3.1 cycle sequen-
cing kits (Applied Biosystems, Foster City, CA) and ana-
lyzed using an ABI 3700XL Genetic Analyzer.
Mutational analysis
Segregation of the mutations was studied in all family
members. In addition, 108 negative samples and 56
ARNSHL families were also screened for the mutations by
direct sequencing. Genotyping for c.IVS25 + 3G > A and
c.8375 T > C was performed by PCR (Additional file 1:
Table S1) and detected by bidirectional sequencing of the
amplified fragments using an automated DNA sequencer
(ABI 3100; Applied Biosystems). Nucleotide alteration(s)
were identified by sequence alignment with the MYO15A
GenBank sequence (NM_016239) using Genetool software.
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Multiple sequence alignment was performed according
to a Homologene program with default settings and the
sequences NP_057323.3 (H. sapiens), XP_0002888352.1
(M. mulatta), XP_003315632.1 (P. troglodytes), XP_00270
7808.1 (B. taurus), XP_536660.3 (C. lupus), NP_034992.2
(M. musculus), XP_577100.2 (R. norvegicus), XP_414818.3




We used Fruitfly (see URL2) analysis to evaluate the effect
of c.IVS25 + 3 G >A on splice site. A 2.0 kb genomic
DNA fragment encompassing the region harboring the
mutation was involved.
Model building and structural-based analysis
Three-dimensional (3D) modeling of the human wild type
and p.V2792A mutation were performed using SWISS-
MODEL, an automated homology modeling program (see
URL3). This study used the automatic modeling approachFigure 1 Combined figure. A. Pedigree of Family 4792 with ARNSHL Affe
Audiogram of affected subjects showed hearing loss ranged from severe to
showing the compound heterozygous mutations (c.IVS25 + 3G > A and c.83to apply the complete protein sequence of human myosin
XVa, including its 3519 amino acids and its mutation,
which are available in the NCBI GenBank (NP_057323.3)
in FASTA format. Data obtained by the homology models
were visualized using Swiss-PdbViewer 4.1.
Results
Clinical presentation of family 4794
Family 4794 includes two affected siblings (31 and
25 years old) and two unaffected parents (Figure 1A).
Audiograms of the affected siblings showed that the hear-
ing loss was bilateral and severe to profound (Figure 1B).
The affected individuals did not have delays in gross
motor development; neither did they have balance prob-
lems. Tandem walking was normal, and the Romberg
test was negative. CT scan of the temporal bone in the
proband excluded inner-ear malformations. The parents
reported no history of stillbirth or miscarriage. Physical
examination of all family members revealed no signs of
systemic illness or dysmorphic features. The remaining
examination results were normal. This phenotype is
consistent with that reported previously for DFNB3
[19]. No mutations were found in SLC26A4 and GJB2,cted subjects are denoted in black. Arrow indicates the proband; B.
profound.; C. Electropherograms analysis of MYO15A in family 4792
75C > T) co-segregated with the phenotype.
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two patients.
Whole-exome sequencing
We applied whole-exome sequencing to the two affected
siblings and two unaffected parents: I1, I2, II:1, and II:2.
The reads were aligned with the human genome reference
sequence. On average, we generated 8.71 billion bases of
sequence with mean target region depths of 74.5. Approxi-
mately 99.2% (4805 mb in length) of the targeted bases
were covered sufficiently to pass our thresholds for calling
SNPs and short insertions or deletions (indels). After identi-
fication of variants, we focused only on non-synonymous
variants, splice acceptor and donor site mutations, and
frameshift coding indels, which were more likely to be
pathogenic than others, especially those in homozygous or
compound heterozygous mode (Additional file 2: Table S2).
On average, we identified 150,306 SNPs in the coding re-
gions and 3,259 variants in introns that may affect splicing
(within 10 bp of the intron/exon junction) for each sample
(Additional file 3: Table S3). Then we compared these
variants with the dbSNP135 (see URL4), HapMap project
(see URL5), 1000 Genome Project (see URL6), and YH
database (see URL7). We identified potential candidate
variants by selecting the homozygous or compound hetero-
zygous variants found in both affected siblings while un-
affected parents contributed equally. Under the autosomal
recessive mode of inheritance, we identified 67 genes with
compound heterozygous variants and 16 genes with homo-
zygous variants. Then we compared these variants to re-
ported nonsyndromic hereditary hearing loss genes; 2
mutations (c.IVS25 + 3G >A, c.8375 T >C) were found in a
previously reported deafness-related gene, MYO15A.Figure 2 Schematic structure of Myosin XVa and conservation analys
alternatively spliced 1223-amino-acid N-terminus encoded by exon 2, a mo
domains, a PDZ domain and an SH3 domain; IVS25 + 3G > A occur betwee
or sequence alignment showed conservation of residues MYO15A IVS25 +
evolutionarily conserved nucleotide or amino acid (in red).Mutation detection and analysis
According to the Berkeley Drosophila Genome Project
(Fruitfly), a change in the splice donor sequence from
GG to AG in intron 25 (c.IVS25 + 3 G > A) of MYO15A,
detected in the present family, is predicted to result in
an increase in splice site recognition by the splicing
factor from 0.58 to 0.96, probably influencing the forma-
tion of the splice donor site.
The c.8375 T >C substitution occurs in exon 47 of
MYO15A and results in a single amino acid substitution,
valine to alanine (p.V2792A), within the FERMa domain.
The V2792 amino acid is conserved across mammalian
species, including human, chimpanzee, dog, mouse, and rat,
as depicted in Figure 2. c.8375 T >C (p.V2792A) was pre-
dicted to be damaging by SIFT and Polyphen2 (see URL8,9).
Both mutations affect the highly preserved residues
(Figure 2). Sanger sequencing validated the two affected
siblings’ mutations and demonstrated that the two parents
were heterozygous carriers of c.IVS25 + 3G >A (mother)
and c.8375 T >C (father), showing complete co-segregation
of the mutation with the phenotype (Figure 1C). The two
mutations were absent both in 108 negative samples and in
56 ARNSHL families. These observations suggest that the
mutation V2792A is likely to have a detrimental effect on
the protein.
Structure modeling of p.V2792
A molecular model of myosin XVa was constructed based
on the crystal structure of the talin head FERM domain
(PDB ID:3ivf), a protein domain that binds F-actin in vitro
and in vivo at a specific site within the actin filament. The
constructed model covered the target sequence of myosin
XVa (residues 2685–2896). Although the sequence identityis. Diagram of the human MYO15A domains which consists of an
tor domain, two IQ motifs, and two MyTH4 domains, two FERM
n IQ and MyTH4 domain, V2792A occur in the FERMa domain. Protein
3 and V2792 across nine species. These two mutations occur at an
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than the average 25%, the target area’s sequence similarity
is high. Using the Swiss-Pdb Viewer 4.1, we show that the
mutation is predicted to perturb the amino acid side chain
because of the substitution of valine to alanine. This region
of the protein is predicted to be highly hydrophobic, as
previously shown in a hydrophobicity plot (Figure 3).
These data, together with the clinical presentation of
the two affected siblings, clearly indicate that MYO15A
mutations are the cause of the ARNSHL in this family.
Discussion
Despite previous intensive linkage analysis and candidate
gene screening, a large proportion of ARNSHL remain
genetically unexplained. WES provides unprecedented
opportunities to identify causative DNA mutations in
rare heritable disorders. This report describes a Chinese
family whose hearing impairment is caused by novel
compound heterozygous mutations in MYO15A gene.
Mutations in this gene have previously been described to
cause autosomal recessive hearing loss.
Human myosin XVa consists of an N-terminal domain
(amino acids 1–1,223), motor domain, neck region, and
tail domain. The motor domain (amino acids 1,224–1,899)
contains two binding sites for ATP and actin, the switches
I and II helix, a relay helix, an SH3 helix, an SH1/SH2
helix, and a converter domain. The neck region containsFigure 3 Structure of wild-type and mutant 2792 of Myosin XVa. A: w
ated by SWISS-MODEL and shown with Swiss-PdbViewer 4.1).two light-chain binding motifs (1,909–1,942). The tail
region contains two MyTH4 (myosin tail homology 4)
domains (2,066–2,174 and 3,051–3,161), two FERM do-
mains (2,687–2,867 and 3,217–3,497) that have a role in
binding of cytoskeletal proteins to cytoplasmic domains of
transmembrane proteins, a putative SH3 domain (2,865–
2,959), and a C-terminal class I PDZ-binding motif
[20,21]. The myosin XVa protein has been shown to be in-
tegral for development and elongation of the stereocilia
through delivery of whirlin to the tips of the stereocilia.
Whirlin binds to the SH3-MYTH4-FERM-domain-con-
taining region of the myosin XVa protein and regulates
actin filament elongation. There have been several reports
of mutations in MYO15A causing hearing loss [17,21-27].
Forty-seven mutations have previously been reported in
MYO15A, and primarily occur in the motor domain.
The c.8375 T > C (p.V2792A) mutation is located
within exon 47 and predicted to lie in the first FERM
domain of myosin XVa. Three mutations in this domain
(Q2716H, D2720H, D2823N) have been reported. The
FERM domain is a widespread protein module involved
in localizing protein to the plasma membrane, and its
amino acid sequence is highly conserved [28].
In this family, a novel splice site mutation c.IVS25 +
3G > A was found in intron 25 of MYO15A and is pre-
dicted to change the highly conserved donor splice site
of intron 25 from GG to AG. Mutations at splice sitesild-type V2792 has side chain; B: mutant A2792 has no side chain (Cre-
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abnormal maturation of mRNA, resulting in either exon
skipping or cryptic splice site activation [29]. These pos-
sibilities have not been investigated, and RNA studies
are not possible in this instance because we cannot ob-
tain fresh peripheral blood samples.
In summary, we have reported the clinical and genetic
characteristics of a non-consanguineous Chinese family with
ARNSHL by WES. To identify pathogenic variants, we con-
secutively filtered these variants by subjecting them to an
analytical pipeline for high-confidence variant calling and
annotation and identified novel compound heterozygous
mutations inMYO15A. The identification of additional novel
mutations in MYO15A further confirms the crucial role of
MYO15A in auditory function. These results support se-
quence analysis ofMYO15A in the clinical diagnostic testing
of individuals with ARNSHL. Pre-implantation genetic diag-
nosis might be available for these families.
Web resources
The URLs presented are as follows:






5. HapMap project, ftp://ftp.ncbi.nlm.nih.gov/hapmap
6. 1000 Genome Project, ftp://ftp.1000genomes.ebi.ac.
uk/vol1/ftp




Additional file 1: Table S1. Primers used for potential mutations
amplification.
Additional file 2: Table S2. Overview of data production using WES.
Additional file 3: Table S3. Summary of SNPs for 4 exome capture samples.
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